Anaphylactic shock to defibrotide

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 8, 2006, Pages 1022-

  Artesani, M C ^a  

^a Unita di Allergologia   (Italy)

Author keywords

Anaphylactic shock; Defibrotide; Hypersensitivity

Indexed keywords

ANTICOAGULANT AGENT; DEFIBROTIDE; POLYDEOXYRIBONUCLEOTIDE;

AGED; ANAPHYLACTIC SHOCK; ARTICLE; CASE REPORT; CHRONIC VEIN INSUFFICIENCY; COLLAPSE; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOTENSION; PRIORITY JOURNAL; SKIN MANIFESTATION; URTICARIA; VOMITING;

AGED; ANAPHYLAXIS; CHRONIC DISEASE; DRUG HYPERSENSITIVITY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; POLYDEOXYRIBONUCLEOTIDES; SKIN TESTS; VENOUS INSUFFICIENCY;

EID: 33745772179     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01086.x     Document Type: Article

References (6)

1. Mantovani V, Maniscalco G, Borsani P, Tenconi S, Bruno VD, Leva C et al. Effects of adenosine and defibrotide adjunct to a standard crystalloid cardioplegic solution. J Cardiovasc Surg 2005;46:291-296.
2. Besisik SK, Ozturk GB, Caliskan Y, Sargin D. Complete resolution of transplantation-associated thrombotic microangiopathty and hepatic veno-occlusive disease by defibrotide and plasma exchange. Turk J Gastroenterol 2005;16:34-37.
3. Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogenic stem cell transplantation. Biol Blood Marrow Transplant 2004;10:347-354.
4. Burcoglu-O'Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol 2002;29:2006-2011.
5. Gelister JS, James WE, Fox JA. Preliminary experience with defibrotide in severe lower limb ischaemia. Haemostasis 1986;16(Suppl. 1):63-66.
6. Brochow K, Romano A, Blanca M, Ring J, Picher WJ, Demoly P, ENDA. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:45-51.